Apollomics, Inc.
Apollomics, Inc. (Nasdaq: APLM) is a clinical-stage biopharmaceutical company headquartered in Foster City, California, focused on the discovery and development of oncology therapies designed to be combined with other treatments to harness the immune system and target specific molecular pathways that inhibit cancer. Operating since 2016, Apollomics has a pipeline of nine drug candidates spanning small-molecule targeted drugs and biologics, including late-stage programs such as vebreltinib (Phase 2, NSCLC and solid tumors with cMet dysregulation) and uproleselan (Phase 3 in China for relapsed/refractory AML). The company became publicly traded via a business combination with Maxpro Capital Acquisition Corp. Surfaced as a portfolio company of Qiming and added to the API Evangelist network; as a biopharmaceutical company it publishes no public developer API surface — this profile carries its corporate identity and domain-security posture.
More than an index entry, but the surface is still mostly links rather than artifacts — the cohort most likely to move a full band from modest, well-targeted work.
API Evangelist profiles Apollomics, Inc. the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Apollomics, Inc. scores 15.0/100 (emerging), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Apollomics, Inc.
Each block below is one kind of artifact we hold for Apollomics, Inc.. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Apollomics, Inc. — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/apollomicsinc · machine-readable index on apis.io